Sign In

Christie Medical Holdings to exhibit VeinViewer technology at ONS Congress 2018

VeinViewer improves venipuncture procedure for patients, clinicians

Publication Date: 5/14/2018

MEMPHIS, Tenn.- (May 14, 2018) - Christie® Medical Holdings, a global leader in near infrared vein finder technology, will be showcasing VeinViewer® Flex and VeinViewer Vision2 at ONS Congress 2018 in the Washington DC Convention Center, May 17-19.

Vein finder technology, such as VeinViewer®, has been used for patients in hospitals with hard to find veins for nearly a decade. It is becoming more prominent in home care settings as well. Patients with chronic illness often need continued infusion therapy at home. Repeated IV starts, whether hospital or home care based, lead to deterioration of the patient’s peripheral veins. To address this challenge and avoid multiple needlesticks, home infusion therapy providers are adopting innovative vein finder technologies like VeinViewer.

VeinViewer reduces the time needed to place an IV catheter or draw blood, and improves first stick success rates by up to 100 percent. VeinViewer technology uses near infrared light to project a real-time HD image of the patient’s veins directly on their skin. VeinViewer lets clinicians see vein structures such as valves and bifurcations, which aids in pre-stick decision making for the point of venipuncture and in helping avoid complications.

In its recently released Infusion Therapy Standards of Practice, Infusion Nursing Society mandates the use of vein visualization technology, including near infrared light technology, for patients with difficult venous access or after failed venipuncture attempts. Additionally, the INS recommends that vein visualization technology be used to increase success with peripheral cannulation and decrease the need for central venous access device insertion.

“VeinViewer is the only device of its kind clinically proven to improve the patient experience and impact the quality of care when inserting peripheral IVs,” said George Pinho, president, Christie Medical Holdings. “In light of the recently updated Infusion TherapyStandards of Practice by the INS that highlights the benefits of vein visualization technology, we’re excited to demonstrate VeinViewer at ONS Congress 2018 so clinicians can see firsthand the positive impact our technology has on venous access and patient care.”

Christie Medical Holdings will be displaying VeinViewer at ONS Congress 2018 at booth 253, from May 17-19. B.Braun Medical, Inc. is a distributor of VeinViewer.

To learn more about Christie vein finding devices: VeinViewer Vision2 and VeinViewer Flex please visit www.christiemed.com.

About Christie Medical Holdings, Inc.

Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vein imaging system that allows health care providers to clearly see accessible veins as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit www.christiemed.com.

For cautions associated to Christie Medical Holdings products, please visit www.christiemed.com/cautions.

Follow us on Twitter @christiemed
Follow us on Facebook: VeinViewer

Christie® is a trademark of Christie Digital Systems, USA, Inc., registered in the United States of America and certain other countries.
VeinViewer® is a trademark of Christie Medical Holdings, Inc., registered in the United States of America and certain other countries.